This document summarizes the findings of 95 Cochrane systematic reviews on interventions related to assisted reproductive technology (ART) published up to July 2015. It finds that 32 reviews identified interventions that were effective or promising, 14 found interventions that were ineffective or possibly ineffective, and 13 were unable to draw conclusions due to lack of evidence. The reviews covered topics like ovarian stimulation protocols, embryo culture methods, and pain relief during oocyte retrieval. Interventions shown to be effective included use of a long gonadotropin-releasing hormone agonist protocol, growth hormone supplementation for poor responders, and ultrasound guidance for embryo transfer.
How to practice medicine ? to provide ordinary care or to provide the best available care? Cochrane systematic reviews help u in this issue. This talk illustrates how Cochrane reviews helps with special focus on reproductive medicine
IUI is a basic but effective form of fertiltiy treatment and can be a viable alternative to the expensive IVF / test tube baby treatment that is normally advised.
This presentation will be very useful for the practising gynecologists, IVF specialists and General practitioners who perform IUI.
Even patients on going through this presentation will be more educated about iui.
Please reach out to me on 9833032120 by whatsapp / Telegram or phone call or email on dalalsj@gmail.com for further details / treatment options.
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...Aboubakr Elnashar
Clomiphene citrate or aromatase inhibitors for
superovulation in women with unexplained infertility
undergoing intrauterine insemination:
a prospective
randomized trial
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
3. The Cochrane Collaboration
International collaboration
Prepares, maintains, and disseminates systematic
reviews
Diverse internal structure (Review Groups,
Centres, Fields, Methods Groups, the Consumer
Network)
Cochrane Library
The current resource with the highest methodological
rigor
$235/year or abstracts only
www.cochrane.org
ABOUBAKR ELNASHAR
4. Increasingly, couples are turning to ART for help
with conceiving and ultimately giving birth to a
healthy live baby of their own.
Fertility treatments are complex, and each ART
cycle consists of several steps. If one of the steps is
incorrectly applied, the stakes are high as
conception may not occur.
With this in mind, it is important that each step of
the ART cycle is supported by good evidence from
well-designed studies.
ABOUBAKR ELNASHAR
5. 95 systematic reviews published in The
Cochrane Library up to July 2015 were
included.
All were high quality.
32 reviews identified interventions that were
effective (n = 19) or promising (n = 13)
14 reviews identified interventions that were
either ineffective (n = 2) or possibly ineffective
(n = 12)
13 reviews were unable to draw conclusions
due to lack of evidence.
Farquhar et al, 2015
ABOUBAKR ELNASHAR
6. Results
5 categories
1. Effective interventions:
indicating that the review found evidence of
effectiveness (or improved safety) for an
intervention.
2. Promising interventions =Possibly effective
(more evidence needed): indicating that the review
found some evidence of effectiveness (or improved
safety) for an intervention, but more evidence is
needed.
ABOUBAKR ELNASHAR
7. 3. Ineffective interventions:
indicating that the review found evidence of lack of
effectiveness (or reduced safety) for an
intervention.
4. Possibly ineffective interventions
(more evidence needed): indicating that the review
found evidence suggesting lack of effectiveness (or
reduced safety) for an intervention, but more
evidence is needed.
5. No conclusions possible due to lack of evidence:
indicating that the review found insufficient
evidence to comment on the effectiveness or
safety of an intervention.
ABOUBAKR ELNASHAR
8. 1. INDICATION FOR ART
Promising interventions
(more evidence needed)
• IVF for unexplained subfertility: IVF may be more
effective than IUI plus ovarian stimulation
(low quality evidence).
(Pandian 2012)
ABOUBAKR ELNASHAR
9. No conclusions possible {lack of evidence}
• IVF Vs tubal reanastomosis
(sterilisation reversal) for subfertility after tubal sterilisation:
no RCTs found.
(Yossry 2006)
• IVM in PCOS undergoing ART:
no RCTs found.
(Siristatidis 2011)
ABOUBAKR ELNASHAR
10. 2. Pre-ART and adjuvant strategies
Effective interventions
• Endometrial injury in women undergoing ART:
performed in the month prior to ovulation induction:
increase both LBR or OPR and CPR
(moderate quality evidence).
•No evidence of a difference between the groups in
miscarriage, multiple pregnancy or bleeding rates.
•Endometrial injury on the day of OR: lower LBR or
OPL
(low quality evidence).
(Nastri , 2015)
ABOUBAKR ELNASHAR
11. • Growth hormone for IVF:
in poor responders: significant improvement in LBR
(moderate quality evidence).
(Duffy 2010)
• Metformin treatment before and during IVF or
ICSI in women with PCOS:
No conclusive evidence for improved LBR
(low quality evidence).
Met increased CPR and decreased risk of OHSS
(moderate quality evidence).
(Tso, 2014)
ABOUBAKR ELNASHAR
12. • Surgical treatment for hydrosalpix:
laparoscopic tubal occlusion is an alternative to
laparoscopic salpingectomy in improving IVF PR
(moderate quality evidence).
(Johnson, 2010)
ABOUBAKR ELNASHAR
13. Possibly effective=Promising interventions
(more evidence needed)
• Antioxidants for male subfertility or unexplained
subfertility
may improve LBR, but more evidence is needed
(low quality evidence).
(Showell 2014)
• Vasodilators for women undergoing fertility tt:
may increase CPR (few studies)
No clear effect was found on LBR
(low quality evidence).
(Gutarra-Vilchez, 2014)
ABOUBAKR ELNASHAR
14. Possibly ineffective interventions
(more evidence needed)
• Acupuncture and ART:
no evidence that improves LBR
(low quality evidence).
(Cheong 2013)
• Interventions for women with endometrioma prior
to ART:
no evidence of an effect on reproductive outcomes
Therapies included: surgery, medicines and
expectant management
(low quality evidence).
(Benschop 2010)
ABOUBAKR ELNASHAR
15. • Antioxidants for female subfertility:
not associated with an increased LBR or CPR,
though more evidence is needed
(low quality evidence).
(Showell ,2013)
• Ovarian cyst aspiration prior to IVF:
no evidence that is associated with increased CPR
(low quality evidence).
None of the studies reported live birth.
(McDonnell 2014)
ABOUBAKR ELNASHAR
16. No conclusions possible due to lack of
evidence
• Preconception lifestyle advice for people with
subfertility:
insufficient evidence to reach a conclusion, with only
one RCT.
(Anderson 2010)
• Aspirin for IVF:
insufficient evidence from adequately powered RCTs
to reach a conclusion.
(Siristatidis, 2011)
ABOUBAKR ELNASHAR
17. 3. Down-regulation with agonists or antagonists
Effective interventions
• GnRHa protocols for pituitary suppression in ART:
CPR was higher when GnRHa was used in a long
protocol as compared to a short or ultra-short
protocol
(low quality evidence).
(Maheshwari 2011)
• GnRHan for ART:
Antagonist compared with long GnRHa protocols:
reduction in OHSS
No evidence of a difference in LBR
(moderate quality evidence).
(Al-Inany 2011)
ABOUBAKR ELNASHAR
18. • Long-term pituitary down-regulation before IVF for
women with endometriosis:
GnRHa for a period of 3-6 months prior to IVF or
ICSI: increased CPR
(very low quality evidence).
(Sallam, 2006)
ABOUBAKR ELNASHAR
19. Possibly ineffective interventions
(more evidence needed)
• Depot Vs daily administration of GnRHa protocols
for pituitary desensitisation in long protocol
no evidence of a significant difference in LBR or
CPR, but substantial differences could not be ruled
out
(moderate quality evidence).
(Albuquerque 2013)
ABOUBAKR ELNASHAR
20. 4. Ovarian stimulation
Effective interventions
• Rec vs urinary gonadotrophin for ovarian
stimulation in ART:
all available gonadotrophins were equally effective
and safe.
Choice will depend upon:
availability of the product
convenience of its use
associated costs.
Any specific differences are likely to be too small to
justify further research
(high quality evidence).
(van Wely 2011)
ABOUBAKR ELNASHAR
21. • Long-acting FSH vs daily FSH for ART:
medium dose (150 to 180 μg) of long-acting FSH
appeared to be a safe and as effective as daily FSH
in women with unexplained subfertility.
low dose (60 to 120 μg) of long-acting FSH
compared to daily FSH: Reduced LBR
(moderate quality evidence).
(Pouwer, 2015)
ABOUBAKR ELNASHAR
22. Possibly effective= Promising interventions
(more evidence needed)
• rLH for COS in ART:
no evidence that the co-administration of rLH to
rFSH in GnRHa down-regulated women resulted in
more live births than COS with rFSH alone
beneficial effect , in particular with respect to
pregnancy loss
(low quality evidence).
(Mochtar 2007)
ABOUBAKR ELNASHAR
23. • CC for COS in women undergoing IVF:
regimens with CC could be used in COS for IVF
treatment without a reduction in PR
Further evidence is required before they can be
recommended with confidence as alternatives to Gnt
alone in GnRH long or short protocols
(low quality evidence).
(Gibreel , 2012)
ABOUBAKR ELNASHAR
24. • FSH replaced by low-dose hCG in the late follicular
phase Vs FSH alone for ARTs:
not reduce the chance of CPR
an equivalent number of oocytes retrieved
expending less FSH
(very low quality evidence).
(Martins 2013)
ABOUBAKR ELNASHAR
25. • OCP, progestogen or estrogen pretreatment for
ovarian stimulation protocols for women undergoing
ARTs:
improved pregnancy outcomes with progestogen
pre-treatment
poorer pregnancy outcomes with a combined
OCP pre-treatment.
(Smulders 2010)
ABOUBAKR ELNASHAR
26. • Natural cycle IVF for subfertile couples:
No evidence of a significant difference between
natural cycle and standard IVF for outcomes:
live birth
OHSS
clinical pregnancy
multiple pregnancy
(very low quality evidence).
(Allersma 2013)
ABOUBAKR ELNASHAR
27. Possibly ineffective interventions
(more evidence needed)
• Monitoring of stimulated cycles in assisted
reproduction (IVF and ICSI):
no evidence to support cycle monitoring by US plus
serum E2 as more efficacious than cycle monitoring
by ultrasound only on the outcomes of live birth and
pregnancy. A large well-designed RCT is needed
(low quality evidence).
(Kwan, 2014)
ABOUBAKR ELNASHAR
28. No conclusions possible due to lack of
evidence
• Interventions for ’poor responders’ to COH in IVF:
insufficient evidence to support the routine use of
any particular intervention for pituitary down-
regulation, ovarian stimulation or adjuvant therapy
in the management of poor responders to COH in
IVF.
(Pandian , 2010)
ABOUBAKR ELNASHAR
29. 5. Ovulation triggering
Effective interventions
• Rec Vs. u hCG for final oocyte maturation
triggering in IVF and ICSI cycles:
u hCG remains the best choice for final oocyte
maturation triggering in ART
{availability and cost}
(moderate quality evidence).
(Youssef, 2011)
ABOUBAKR ELNASHAR
30. • GnRHa Vs. hCG for oocyte triggering in
antagonist ART cycles:
GnRHa:
lower LBR
reduced OPR
higher miscarriage rate
reduction in OHSS rates
A trade off between benefits and harms (moderate
quality evidence).
(Youssef , 2014)
ABOUBAKR ELNASHAR
31. 6. Oocyte retrieval
Effective interventions
• Pain relief:
5 different categories of conscious sedation and
analgesia appeared to be acceptable and were
associated with a high degree of satisfaction in
women.
The optimal method may be individualised
depending on
preferences of the women and their clinicians
resource availability
(very low quality evidence).
(Kwan , 2013)
ABOUBAKR ELNASHAR
32. Ineffective interventions
• Follicular flushing:
No improved C or OPR
No increase in oocyte yield.
Increase operative time
More opiate analgesia
(moderate quality evidence).
(Wongtra-ngan 2010)
ABOUBAKR ELNASHAR
33. 7. Sperm retrieval
No conclusions possible due to lack of
evidence
• Techniques for surgical retrieval of sperm prior to
ICSI for azoospermia:
insufficient evidence to recommend any specific
sperm retrieval technique for azoospermic men
undergoing ICSI (only one RCT) (low quality
evidence).
(Proctor , 2008)
ABOUBAKR ELNASHAR
34. • Advanced sperm selection techniques for assisted
reproduction:
insufficient evidence to determine whether sperm
selected by hyaluronic acid binding improves LBR
or pregnancy outcomes in ART, or whether there is
a difference in efficacy between the hyaluronic acid
binding methods SpermSlow and PICSI.
No RCT evaluating sperm selection by sperm
apoptosis, sperm birefringence or surface charge
was found (low quality evidence).
(McDowell 2014)
ABOUBAKR ELNASHAR
35. 8. Laboratory phase
Effective interventions
• Low oxygen concentrations for embryo culture in
ART:
:an increase in LBR
(moderate quality evidence).
(Bontekoe , 2012)
ABOUBAKR ELNASHAR
36. Ineffective interventions
• Preimplantation genetic screening for abnormal
number of chromosomes (aneuploidies):
using fluorescent in situ hybridization significantly
decreased LBR in women of advanced maternal
age and those with repeated IVF failure
Trials in which PGS was offered to women with a
good prognosis suggested similar outcomes
(moderate quality evidence).
(Twisk, 2006)
ABOUBAKR ELNASHAR
37. Promising interventions (more evidence
needed)
• Assisted hatching on assisted conception (IVF
and ICSI):
AH appeared to offer an increased CPR, the extent
to which it might do so only just reached statistical
significance.
The ’take home’ baby rate was still not proved to be
increased by AH, and multiple pregnancy rates
were significantly increased in the AH groups
(moderate quality evidence).
(Carney, 2012)
ABOUBAKR ELNASHAR
38. • Brief co-incubation of sperm and oocytes for IVF
techniques:
•brief co-incubation of sperm and oocytes may
improve O and CPR, compared to the standard
overnight insemination protocol. More RCTs are
required (low quality evidence).
(Huang 2013)
• Vitrification probably increases CPR compared to
slow freezing. However the total number of women
and of pregnancies was low and no data were
available on live birth or adverse events (low quality
evidence).
(Glujovsky 2014)
ABOUBAKR ELNASHAR
39. Possibly ineffective interventions (more
evidence needed)
• Regular ICSI Vs. ultra-high magnification (IMSI)
sperm selection:
no evidence of a difference between ICSI and IMSI
with respect to live birth or miscarriage rates, and
evidence suggesting that IMSI improved clinical
pregnancy was of very low quality (very low
quality evidence).
(Teixeira 2013)
ABOUBAKR ELNASHAR
40. No conclusions possible due to lack of
evidence
• ICSI Vs. conventional techniques for oocyte
insemination during IVF in patients with non-male
subfertility:
insufficient evidence to reach a conclusion, with
only one RCT.
(Van Rumste , 2003)
• Time-lapse systems Vs. conventional embryo
incubation and assessment:
insufficient evidence of differences in live birth,
miscarriage, stillbirth or clinical pregnancy to reach
a conclusion.
(Armstrong , 2015)
ABOUBAKR ELNASHAR
41. 9. Embryo transfer
Effective interventions
• Ultrasound versus ’clinical touch’ for catheter
guidance:
significant increase in CPR
(low quality evidence).
(Brown, 2010)
ABOUBAKR ELNASHAR
42. • Adherence compounds in ET media for ART:
use of hyaluronic acid.
improved LBR and CPR with the
Increase Multiple pregnancy rates
(moderate quality evidence).
(Bontekoe, 2014)
ABOUBAKR ELNASHAR
43. • Number of embryos for transfer:
single embryo transfer compared with double
embryo transfer
LBR was lower
fewer multiple pregnancies
(high quality evidence).
cumulative LBR associated with single embryo
transfer followed by a single frozen and thawed ET
was comparable with that after one cycle of double
embryo transfer
(low quality evidence).
(Pandian, 2013)
ABOUBAKR ELNASHAR
44. Promising interventions (more evidence
needed)
• Day 3 versus day 2 ET:
no differences in rates of live birth or clinical
pregnancy between day 3 and day 2 ET.
Although an increase in clinical pregnancy rate with
day 3 ET was demonstrated, there was insufficient
good quality evidence to suggest an improvement
in live birth when embryo transfer was delayed from
day two to day three (low quality evidence).
(Gunby , 2004)
ABOUBAKR ELNASHAR
45. Possibly ineffective interventions (more
evidence needed)
• Techniques for preparation prior to ET:
no evidence of benefit with the following
interventions at the time of ET: full bladder, removal
of cervical mucus, flushing the endocervical canal
or the endometrial cavity.
More and larger studies are needed on ET
preparation techniques.
(Derks, 2009)
ABOUBAKR ELNASHAR
46. • Antibiotics prior to ET:
amoxicillin and clavulanic acid prior to ET reduced
upper genital tract microbial contamination but did
not alter CPR (moderate quality evidence).
no data from RCTs to support or refute other
antibiotic regimens in this setting. Future research
is warranted.
(Kroon, 2012)
ABOUBAKR ELNASHAR
47. No conclusions possible due to lack of
evidence
• Cleavage stage Vs. blastocyst stage ET:
the margin of benefit between cleavage stage and
blastocyst transfer is unclear. Although LBR are
increased with blastocyst transfer it is also
associated with a reduction in the number of
embryos transferred and for embryo freezing.
•Cumulative CPR are increased with cleavage
stage transfer (moderate quality evidence).
•Future RCTs should report miscarriage, live birth
and cumulative LBR to facilitate well-informed
decisions on the best treatment option available.
(Glujovsky, 2012)
ABOUBAKR ELNASHAR
48. •Post-ET interventions:
•insufficient evidence to support a certain amount of
time for women to remain recumbent following ET,
or to support the use of fibrin sealants.
•limited evidence to support the use of mechanical
closure of the cervical canal following ET.
•Further well-designed studies are required.
(Abou-Setta, 2014)
ABOUBAKR ELNASHAR
49. 10. Luteal phase support
Effective interventions
• LPS:
Progesterone appears to be the best method,
higher LBR and OPR than placebo
lower rates of OHSS than hCG.
Addition of one or more doses of GnRHa to
progesterone:
higher LBR and OPR than progesterone alone.
ABOUBAKR ELNASHAR
50. Addition of oestrogen or hCG did not improve
outcomes, and hCG was associated with higher risk
of OHSS.
The route of progesterone administration did not
seem to matter
(quality of evidence low for most comparisons).
(van der Linden, 2015)
ABOUBAKR ELNASHAR
51. Promising interventions (more evidence
needed)
• Heparin:
Peri-implantation LMWH may improve LBR.
However the results did not justify the use of
heparin outside well-conducted research trials, as
evidence quality was poor (very low quality
evidence).
(Akhtar, 2013)
ABOUBAKR ELNASHAR
52. Possibly ineffective interventions (more
evidence needed)
• Peri-implantation glucocorticoid administration:
no clear evidence that administration of peri-
implantation glucocorticoids in ART cycles
significantly improved clinical outcomes (low quality
evidence).
(Boomsma, 2002)
ABOUBAKR ELNASHAR
53. 11. Prevention of OHSS
Effective interventions
•hydroxyethyl starch
decreased the incidence of severe OHSS
(very low quality evidence)
(Youssef 2011)
• Cabergoline:
reduce the risk of OHSS in high risk women,
especially for moderate OHSS
did not affect CPR or miscarriage rates
No increased risk of other adverse events
(low quality evidence).
(Tang, 2012)
ABOUBAKR ELNASHAR
54. • GnRHan compared with long GnRHa protocols:
reduction in OHSS
no evidence of a difference in LBR
(moderate quality evidence).
(Al-Inany, 2011)
ABOUBAKR ELNASHAR
55. • GnRHa versus hCG for oocyte triggering in
antagonist ART cycles:
lower LBR
reduced OPR
higher miscarriage rate
reduction in OHSS rates
a trade off between benefits and harms
(moderate quality evidence).
(Youssef , 2014)
ABOUBAKR ELNASHAR
56. Possibly ineffective interventions (more
evidence needed)
• Embryo freezing for preventing OHSS:
insufficient evidence to support routine
cryopreservation and insufficient evidence for the
relative merits of intravenous albumin versus
cryopreservation (low quality evidence).
(D’Angelo, 2007)
• Coasting (withholding gonadotrophins):
insufficient evidence to confirm whether there is any
benefit from using coasting to prevent OHSS
compared with no coasting or other interventions
(very low quality evidence).
(D’Angelo, 2011)
ABOUBAKR ELNASHAR
57. 12. Frozen embryo replacement cycles
No conclusions possible due to lack of
evidence
• Cycle regimens for frozen-thawed ET:
insufficient evidence to support the use of one
intervention in preference to another.
(Ghobara, 2008)
• Endometrial preparation for women undergoing ET
with frozen embryos or embryos derived from donor
oocytes:
insufficient evidence to recommend any one
particular protocol for endometrial preparation over
another with regard to CPR after ET.
(Glujovsky, 2010)
ABOUBAKR ELNASHAR
58. This overview summarises published Cochrane
systematic reviews of all randomised controlled
trials on the different stages of an ART cycle and the
different populations undergoing ART.
We consider it to be complete, although we also
acknowledge that not all systematic reviews in this
overview are up to date. We consider that the
information in this study can be applied to couples
undergoing an ART cycle in most parts of the world,
including using low cost strategies such as modified
natural cycle IVF.
ABOUBAKR ELNASHAR
59. C O N C L U S I O N S
This overview provides the most up to date
evidence on ART cycles from systematic reviews of
RCT.
Fertility treatments are costly and the stakes are
high. Best practice requires using the best available
evidence to optimise outcomes.
The evidence from this overview could be used to
develop clinical practice guidelines and protocols for
use in daily clinical practice, in order to improve
LBR and reduce rates of multiple pregnancy, cycle
cancellation and OHSS.
ABOUBAKR ELNASHAR